©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 109869
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109869
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109869
Table 4 Effect of fluid resuscitation on organ failure and clinical outcomes, mean ± SD/n (%)/median (interquartile range)
| Parameter | Intervention group A, n = 55 | Control group, n = 53 | P value |
| Local complications at 3 months | 11 (20.00) | 15 (28.30) | 0.4 |
| Pancreatic necrosis at 3 months | 4 (7.27) | 5 (9.43) | 0.7 |
| Pseudocysts at 3 months | 7 (12.73) | 10 (18.87) | 0.5 |
| Infected local complications | 5 (9.09) | 7 (13.21) | 0.7 |
| Organ failure at 72 hours | 2 (3.64) | 7 (12.20) | NA |
| OF respiratory (PaO2/FiO2 < 300) at 72 hours | 1 (1.82) | 5 (9.43) | NA |
| OF creatinine (> 1.9 mg/dL) at 72 hours | 0 (0) | 0 (0) | NA |
| OF cardiovascular at 72 hours | 1 (1.82) | 2 (3.77) | NA |
| Total hospital stays in days | 5 (4-7) | 6 (5-7) | 0.1 |
| ICU stay in days | 0.0 ± 0.0 | 0.0 ± 0.2 | |
| OF at 3 months | 1 (1.82)1 | 2 (3.77)1 | NA |
| 30-day mortality rate | 0 (0) | 1 (1.89) | NA |
| 3-month mortality rate | 1 (1.82) | 1 (1.89) | NA |
- Citation: Costea NC, Vesa S, Toma M, Pojoga C, Seicean A. Fluid therapy strategies in acute pancreatitis: Randomized controlled trial comparing dextran and Ringer’s lactate. World J Gastrointest Surg 2025; 17(11): 109869
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/109869.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.109869